Interventional Cardiology

Science News

VIDEO: The American Heart Association Response to the COVID-19 Crisis
Health Equity and Structural Racism Language Guide (PDF)
Call to Action: Structural Racism as a Fundamental Driver of Health Disparities
Prevention of Complications in the Cardiac Intensive Care Unit
Contemporary Diagnosis and Management of Rheumatic Heart Disease

Journals

Safety and Outcome of Carotid Dissection Stenting During the Treatment of Tandem Occlusions
One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk Patients
Standards of Care in Crisis
Institutional Red Blood Cell Transfusion Rates Are Correlated Following Endovascular and Surgical Cardiovascular Procedures: Evidence That Local Culture Influences Transfusion Decisions
Mobile Interventional Stroke Team Model Improves Early Outcomes in Large Vessel Occlusion Stroke

Continuing Education

Registration Now Open

The CVRI Council’s mission is to provide leadership to the AHA to reduce death and disability from cardiovascular, peripheral vascular, and cerebrovascular diseases, using diagnostic and functional imaging and imaging-directed interventions. Council partners work to provide outstanding research, education, outreach, and mentorship opportunities.


The CLCD Council supports AHA objectives in clinical cardiology, promotes excellent clinical care, and fosters professional development and education for clinical cardiologists. Through council-sponsored symposia, panels, and scientific conferences, partners can access and interpret new developments in the field and promote clinical cardiology to professional and lay audiences.


The CVSN Council accelerates the discovery, interpretation, and application of science to enhance cardiovascular health and treat cardiovascular diseases and stroke. The council helps develop scientific statements and advisories, guide professional education activities, provide scientific expertise, conduct research, translate findings, and promote evidence-based practices in clinical settings.


TAVR Low Risk Bicuspid Study | Basel Ramlawi, MD

Co-Principal Investigator Basel Ramlawi, MD summarizes the results of the TAVR Low Risk Bicuspid Study which he presented virtually for ACC 2020. The prospective single-arm interventional study examined TAVR for patients with severe aortic stenosis. See this study and other late-breaking science presentations on our AHA Science News from ACC 2020 page.

American Heart Association Professional Partners

Enjoy instant benefits!

  • Free Online Access to AHA Scientific Journals
  • Affiliate with our 16 Scientific Councils
  • Discounts on Scientific Conference Registration and Online Courses